Charles Schwab’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-11,225
| Closed | -$96.6K | – | 3543 |
|
2025
Q1 | $96.6K | Sell |
11,225
-1,280
| -10% | -$11K | ﹤0.01% | 3348 |
|
2024
Q4 | $447K | Hold |
12,505
| – | – | ﹤0.01% | 3172 |
|
2024
Q3 | $591K | Hold |
12,505
| – | – | ﹤0.01% | 3105 |
|
2024
Q2 | $628K | Buy |
12,505
+670
| +6% | +$33.7K | ﹤0.01% | 3098 |
|
2024
Q1 | $1.33M | Sell |
11,835
-488
| -4% | -$54.7K | ﹤0.01% | 2709 |
|
2023
Q4 | $715K | Buy |
12,323
+547
| +5% | +$31.7K | ﹤0.01% | 2947 |
|
2023
Q3 | $374K | Sell |
11,776
-21,052
| -64% | -$668K | ﹤0.01% | 3153 |
|
2023
Q2 | $2.7M | Buy |
32,828
+3,641
| +12% | +$299K | ﹤0.01% | 2458 |
|
2023
Q1 | $3M | Buy |
29,187
+2,346
| +9% | +$241K | ﹤0.01% | 2412 |
|
2022
Q4 | $3.93M | Buy |
26,841
+1,095
| +4% | +$160K | ﹤0.01% | 2337 |
|
2022
Q3 | $4.35M | Sell |
25,746
-501
| -2% | -$84.7K | ﹤0.01% | 2287 |
|
2022
Q2 | $3.03M | Buy |
26,247
+7,661
| +41% | +$885K | ﹤0.01% | 2410 |
|
2022
Q1 | $1.85M | Sell |
18,586
-934
| -5% | -$93.2K | ﹤0.01% | 2671 |
|
2021
Q4 | $3.04M | Buy |
19,520
+228
| +1% | +$35.5K | ﹤0.01% | 2565 |
|
2021
Q3 | $4.55M | Buy |
19,292
+2,793
| +17% | +$659K | ﹤0.01% | 2422 |
|
2021
Q2 | $5.6M | Buy |
16,499
+1,692
| +11% | +$574K | ﹤0.01% | 2296 |
|
2021
Q1 | $5.99M | Buy |
14,807
+477
| +3% | +$193K | ﹤0.01% | 2205 |
|
2020
Q4 | $9.53M | Buy |
14,330
+191
| +1% | +$127K | ﹤0.01% | 1894 |
|
2020
Q3 | $6.58M | Buy |
14,139
+9,391
| +198% | +$4.37M | ﹤0.01% | 1937 |
|
2020
Q2 | $2.78M | Buy |
4,748
+1,304
| +38% | +$763K | ﹤0.01% | 2299 |
|
2020
Q1 | $502K | Buy |
3,444
+42
| +1% | +$6.12K | ﹤0.01% | 2712 |
|
2019
Q4 | $488K | Hold |
3,402
| – | – | ﹤0.01% | 2822 |
|
2019
Q3 | $135K | Hold |
3,402
| – | – | ﹤0.01% | 3080 |
|
2019
Q2 | $345K | Buy |
3,402
+2,008
| +144% | +$204K | ﹤0.01% | 2970 |
|
2019
Q1 | $184K | Buy |
1,394
+414
| +42% | +$54.6K | ﹤0.01% | 3036 |
|
2018
Q4 | $100K | Sell |
980
-144
| -13% | -$14.7K | ﹤0.01% | 3088 |
|
2018
Q3 | $281K | Buy |
1,124
+144
| +15% | +$36K | ﹤0.01% | 3018 |
|
2018
Q2 | $438K | Buy |
980
+168
| +21% | +$75.1K | ﹤0.01% | 2845 |
|
2018
Q1 | $321K | Buy |
+812
| New | +$321K | ﹤0.01% | 2853 |
|